Biocad
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Biocad
RECRUITINGPhase 1 / Phase 2NCT06120582
Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)
The goal of this multicenter, two-stage, open-label study is to investigate the safety, immunogenicity, and efficacy of ANB-002 in subjects with hemophilia В. The study will have...
Sponsor: BiocadEnrolling: 2817 locations
Hemophilia B
RECRUITINGPhase 3NCT06700096
An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients...
The aim of the study is to demonstrate non-inferiority of ANB-002 compared with preventive use of coagulation factor IX (FIX) in adult subjects with hemophilia B with FIX activity...
Sponsor: BiocadEnrolling: 2414 locations
Hemophilia B
RECRUITINGPhase 1 / Phase 2NCT05747261
Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous...
The goal of this multicenter, open-label, non-comparative, cohort study is to investigate the safety, immunogenicity, and efficacy of ANB-004 in children with spinal muscular...
Sponsor: BiocadEnrolling: 407 locations
Spinal Muscular Atrophy (SMA)